You are about to leave Helsinn's Corporate US Website.

Please click 'Continue to external site' if you want to continue.

Our Management Team

Our Management Team brings together wide-ranging expertise from across the whole of cancer care and rare diseases through product development of therapies through to commercialization products. We’re focused on pushing further to deliver more life-changing treatments for people with cancer today and in the future.

Our Board

Our Board

Helsinn’s Senior Executive Committee Team

Riccardo Braglia

Group Vice Chairman & CEO, Board Member & US Chairman

Giorgio Calderari

Group General Manager & Chief Operating Officer & U.S. Board Member

Matteo Missaglia

Group General Counsel and Chief Legal Officer

Konrad Wilson

Group Chief Financial Officer

Andrea Meoli

Group Chief Commercial Officer

Sergio Cantoreggi

Group Chief Scientific Officer and Global Head of R&D

Helsinn's Management Team

Waldo Mossi

Local General Manager, Helsinn Advanced Synthesis SA, Switzerland

Deirdre Hurley

Local General Manager, Helsinn Birex Pharmaceuticals Ltd., Ireland

Paul Rittman

Local CEO, Helsinn Therapeutics (U.S.), Inc., USA

Enrico Magnani

Local General Manager, Helsinn Pharmaceuticals (Beijing) Co., Ltd., P.R.C.

Cristina Marenzi

Group Head of Human Resources

Roberta Cannella

Group Head of Manufacturing and CMC

Matteo Santi

Group Compliance Officer and Group Head of Compliance and Quality

Roberto Lazari

Group Head of Information and Communications Technology

Georg Büchner

Group Head of Business Development